Literature DB >> 24433920

In vitro and in vivo degradation evaluation of novel iron-bioceramic composites for bone implant applications.

M F Ulum1, A Arafat2, D Noviana3, A H Yusop4, A K Nasution5, M R Abdul Kadir4, H Hermawan6.   

Abstract

Biodegradable metals such as magnesium, iron and their alloys have been known as potential materials for temporary medical implants. However, most of the studies on biodegradable metals have been focusing on optimizing their mechanical properties and degradation behavior with no emphasis on improving their bioactivity behavior. We therefore investigated the possibility of improving iron biodegradation rate and bioactivity by incorporating various bioactive bioceramics. The iron-based bioceramic (hydroxyapatite, tricalcium phosphate and biphasic calcium phosphate) composites were prepared by mechanical mixing and sintering process. Degradation studies indicated that the addition of bioceramics lowered the corrosion potential of the composites and slightly increased their corrosion rate compared to that of pure iron. In vitro cytotoxicity results showed an increase of cellular activity when rat smooth muscle cells interacted with the degrading composites compared to pure iron. X-ray radiogram analysis showed a consistent degradation progress with that found in vivo and positive tissue response up to 70 days implantation in sheep animal model. Therefore, the iron-based bioceramic composites have the potential to be used for biodegradable bone implant applications.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioceramics; Biodegradable metals; Cytotoxicity; Degradation; Implantation; Iron

Mesh:

Substances:

Year:  2013        PMID: 24433920     DOI: 10.1016/j.msec.2013.12.022

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  8 in total

Review 1.  Iron and iron-based alloys for temporary cardiovascular applications.

Authors:  A Francis; Y Yang; S Virtanen; A R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2015-02-26       Impact factor: 3.896

Review 2.  Progress in manufacturing and processing of degradable Fe-based implants: a review.

Authors:  V P Muhammad Rabeeh; T Hanas
Journal:  Prog Biomater       Date:  2022-05-18

3.  Proliferation and differentiation of mesenchymal stem cells on scaffolds containing chitosan, calcium polyphosphate and pigeonite for bone tissue engineering.

Authors:  S Dhivya; A Keshav Narayan; R Logith Kumar; S Viji Chandran; M Vairamani; N Selvamurugan
Journal:  Cell Prolif       Date:  2017-11-21       Impact factor: 6.831

4.  Controlling the degradation kinetics of porous iron by poly(lactic-co-glycolic acid) infiltration for use as temporary medical implants.

Authors:  Abdul Hakim Md Yusop; Nurizzati Mohd Daud; Hadi Nur; Mohammed Rafiq Abdul Kadir; Hendra Hermawan
Journal:  Sci Rep       Date:  2015-06-09       Impact factor: 4.379

5.  Accelerating degradation rate of pure iron by zinc ion implantation.

Authors:  Tao Huang; Yufeng Zheng; Yong Han
Journal:  Regen Biomater       Date:  2016-06-05

6.  Inflammatory and Immunogenic Response of the Tissue after Application of Freeze-Dried Hydroxyapatite Gypsum Puger Scaffold Compared to Freeze-dried Hydroxyapatite Bovine Scaffold.

Authors:  Amiyatun Naini; Mohamad Rubianto; Fourier Dzar Eljabbar Latief; Achmad Gunadi; Dewi Kristiana; Nike Hendrijantini; I Ketut Sudiana
Journal:  Contemp Clin Dent       Date:  2020-12-20

7.  In vitro degradation and surface bioactivity of iron-matrix composites containing silicate-based bioceramic.

Authors:  Sanguo Wang; Yachen Xu; Jie Zhou; Haiyan Li; Jiang Chang; Zhiguang Huan
Journal:  Bioact Mater       Date:  2016-12-20

Review 8.  Cationic Substitutions in Hydroxyapatite: Current Status of the Derived Biofunctional Effects and Their In Vitro Interrogation Methods.

Authors:  Teddy Tite; Adrian-Claudiu Popa; Liliana Marinela Balescu; Iuliana Maria Bogdan; Iuliana Pasuk; José M F Ferreira; George E Stan
Journal:  Materials (Basel)       Date:  2018-10-24       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.